Double‐Blind, Randomized, Placebo‐Controlled Trial of DA‐9701 in Parkinson's Disease: PASS‐GI Study

OBJECTIVES: This study aimed to assess the efficacy of DA‐9701 on gastrointestinal symptom‐related quality of life in patients with Parkinson's disease on stable dopaminergic medications. METHODS: This multicenter, double‐blind, placebo‐controlled, phase 4 trial included a total of 144 patients...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mov Disord
Asıl Yazarlar: Choi, Ji‐Hyun, Lee, Jee‐Young, Cho, Jin Whan, Koh, Seong‐Beom, Yang, Young Soon, Yoo, Dalla, Shin, Cheol‐Min, Kim, Hee Tae
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2020
Konular:
Regular Issue Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754502/
https://ncbi.nlm.nih.gov/pubmed/32761955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.28219
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller